Corticorelin ovine is an analogue of the naturally occurring human corticotropin-releasing hormone (hCRH) peptide. Corticorelin ovine is a potent stimulator of adrenocorticotropic hormone (ACTH) release from the anterior pituitary. ACTH stimulates cortisol production from the adrenal cortex. Corticorelin ovine was marketed under the brand name ACTHREL for use in differentiating pituitary and ectopic production of ACTH in patients with ACTH-dependent Cushing’s syndrome.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P34998 Gene ID: 104909134|||1394 Gene Symbol: CRHR1 Target Organism: Homo sapiens (Human) |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Diagnostic | ACTHREL Approved UseACTHREL® is indicated for use in differentiating pituitary and ectopic production of ACTH in patients with ACTH-dependent Cushing’s syndrome. Launch Date1996 |
Sample Use Guides
A single intravenous dose of ACTHREL® (corticorelin ovine) at 1 mcg/kg is recommended for the testing of pituitary corticotrophin function. A dose of 1 mcg/kg is the lowest dose that produces maximal cortisol responses and significant (though apparently sub-maximal) ACTH responses. Doses above 1 mcg/kg are not recommended.
Route of Administration:
Intravenous
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 22:43:10 GMT 2025
by
admin
on
Mon Mar 31 22:43:10 GMT 2025
|
| Protein Sub Type | |
| Record UNII |
56X54T817Q
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C394
Created by
admin on Mon Mar 31 22:43:10 GMT 2025 , Edited by admin on Mon Mar 31 22:43:10 GMT 2025
|
||
|
FDA ORPHAN DRUG |
35089
Created by
admin on Mon Mar 31 22:43:10 GMT 2025 , Edited by admin on Mon Mar 31 22:43:10 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB09067
Created by
admin on Mon Mar 31 22:43:10 GMT 2025 , Edited by admin on Mon Mar 31 22:43:10 GMT 2025
|
PRIMARY | |||
|
100000155305
Created by
admin on Mon Mar 31 22:43:10 GMT 2025 , Edited by admin on Mon Mar 31 22:43:10 GMT 2025
|
PRIMARY | |||
|
56X54T817Q
Created by
admin on Mon Mar 31 22:43:10 GMT 2025 , Edited by admin on Mon Mar 31 22:43:10 GMT 2025
|
PRIMARY | |||
|
121249-14-7
Created by
admin on Mon Mar 31 22:43:10 GMT 2025 , Edited by admin on Mon Mar 31 22:43:10 GMT 2025
|
PRIMARY | |||
|
SUB129331
Created by
admin on Mon Mar 31 22:43:10 GMT 2025 , Edited by admin on Mon Mar 31 22:43:10 GMT 2025
|
PRIMARY | |||
|
74670
Created by
admin on Mon Mar 31 22:43:10 GMT 2025 , Edited by admin on Mon Mar 31 22:43:10 GMT 2025
|
PRIMARY | RxNorm | ||
|
CHEMBL1201591
Created by
admin on Mon Mar 31 22:43:10 GMT 2025 , Edited by admin on Mon Mar 31 22:43:10 GMT 2025
|
PRIMARY | |||
|
121494108
Created by
admin on Mon Mar 31 22:43:10 GMT 2025 , Edited by admin on Mon Mar 31 22:43:10 GMT 2025
|
PRIMARY | |||
|
SUB23368
Created by
admin on Mon Mar 31 22:43:10 GMT 2025 , Edited by admin on Mon Mar 31 22:43:10 GMT 2025
|
PRIMARY | |||
|
56X54T817Q
Created by
admin on Mon Mar 31 22:43:10 GMT 2025 , Edited by admin on Mon Mar 31 22:43:10 GMT 2025
|
PRIMARY | |||
|
C47463
Created by
admin on Mon Mar 31 22:43:10 GMT 2025 , Edited by admin on Mon Mar 31 22:43:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
STARTING MATERIAL -> INGREDIENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| SALT FORMATION | CHEMICAL |
|
Trifluoroacetic acid | E5R8Z4G708 |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO ACID SUBSTITUION | [1_41] | Ala | ALANINAMIDE, L- | GOD06L4T27 |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|